The drug that slows the advance of vitiligo

A few years ago a patient suffering from rheumatoid arthritis was treated, as was and still is done today, with a jak-inhibitor, a drug that interferes with the activities of a family of enzymes involved in inflammatory and autoimmune processes, the janus-kinases, Jak, in fact. The patient in question, in addition to suffering from rheumatoid arthritis, was also suffering from vitiligo.